Pilati, L.; Torrente, A.; Di Marco, S.; Ferlisi, S.; Notaro, G.; Romano, M.; Alonge, P.; Vassallo, L.; Ferraù, L.; Autunno, M.;
et al. Erenumab and Possible CGRP Effect on Chronotype in Chronic Migraine: A Real-Life Study of 12 Months Treatment. J. Clin. Med. 2023, 12, 3585.
https://doi.org/10.3390/jcm12103585
AMA Style
Pilati L, Torrente A, Di Marco S, Ferlisi S, Notaro G, Romano M, Alonge P, Vassallo L, Ferraù L, Autunno M,
et al. Erenumab and Possible CGRP Effect on Chronotype in Chronic Migraine: A Real-Life Study of 12 Months Treatment. Journal of Clinical Medicine. 2023; 12(10):3585.
https://doi.org/10.3390/jcm12103585
Chicago/Turabian Style
Pilati, Laura, Angelo Torrente, Salvatore Di Marco, Salvatore Ferlisi, Giulia Notaro, Marika Romano, Paolo Alonge, Lavinia Vassallo, Ludovica Ferraù, Massimo Autunno,
and et al. 2023. "Erenumab and Possible CGRP Effect on Chronotype in Chronic Migraine: A Real-Life Study of 12 Months Treatment" Journal of Clinical Medicine 12, no. 10: 3585.
https://doi.org/10.3390/jcm12103585
APA Style
Pilati, L., Torrente, A., Di Marco, S., Ferlisi, S., Notaro, G., Romano, M., Alonge, P., Vassallo, L., Ferraù, L., Autunno, M., Grugno, R., Camarda, C., & Brighina, F.
(2023). Erenumab and Possible CGRP Effect on Chronotype in Chronic Migraine: A Real-Life Study of 12 Months Treatment. Journal of Clinical Medicine, 12(10), 3585.
https://doi.org/10.3390/jcm12103585
